PT1220662E - Sistema terapeutico percutaneo que contem cloridrato de tulobuterol para administrar o tulobuterol broncodilatador atraves da pele - Google Patents

Sistema terapeutico percutaneo que contem cloridrato de tulobuterol para administrar o tulobuterol broncodilatador atraves da pele

Info

Publication number
PT1220662E
PT1220662E PT00966123T PT00966123T PT1220662E PT 1220662 E PT1220662 E PT 1220662E PT 00966123 T PT00966123 T PT 00966123T PT 00966123 T PT00966123 T PT 00966123T PT 1220662 E PT1220662 E PT 1220662E
Authority
PT
Portugal
Prior art keywords
tulobuterol
bronchodylator
chloridrate
administrate
skin
Prior art date
Application number
PT00966123T
Other languages
English (en)
Portuguese (pt)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of PT1220662E publication Critical patent/PT1220662E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT00966123T 1999-10-16 2000-10-06 Sistema terapeutico percutaneo que contem cloridrato de tulobuterol para administrar o tulobuterol broncodilatador atraves da pele PT1220662E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19950066A DE19950066A1 (de) 1999-10-16 1999-10-16 Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut

Publications (1)

Publication Number Publication Date
PT1220662E true PT1220662E (pt) 2005-10-31

Family

ID=7925993

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00966123T PT1220662E (pt) 1999-10-16 2000-10-06 Sistema terapeutico percutaneo que contem cloridrato de tulobuterol para administrar o tulobuterol broncodilatador atraves da pele

Country Status (12)

Country Link
US (1) US7056528B1 (https=)
EP (1) EP1220662B1 (https=)
JP (2) JP4874486B2 (https=)
KR (1) KR101014074B1 (https=)
AR (1) AR026040A1 (https=)
AT (1) ATE299019T1 (https=)
AU (1) AU7662400A (https=)
CA (1) CA2387143C (https=)
DE (2) DE19950066A1 (https=)
ES (1) ES2245648T3 (https=)
PT (1) PT1220662E (https=)
WO (1) WO2001028531A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
WO2004112770A1 (ja) * 2003-06-20 2004-12-29 Teikoku Seiyaku Co., Ltd. ツロブテロール含有貼付剤
DE10340152B4 (de) 2003-09-01 2006-05-04 BÖCO Böddecker & Co. GmbH & Co. KG Schloß mit einer Drehfalle und einer Sperrklinke
CA2542778C (en) * 2003-10-28 2012-05-29 Noven Pharmaceuticals, Inc. Transdermal drug delivery composition
CN1297257C (zh) * 2004-01-02 2007-01-31 上海现代药物制剂工程研究中心有限公司 含有妥洛特罗的压敏胶，透皮贴剂及制备方法和应用
WO2006051818A1 (ja) * 2004-11-10 2006-05-18 Hisamitsu Pharmaceutical Co., Inc. 外用製剤及び貼付剤
EP1806151B1 (en) * 2004-11-10 2012-05-23 Hisamitsu Pharmaceutical Co., Inc. Drug for external use and adhesive patch
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
CA3172541C (en) * 2009-06-05 2026-04-14 Durr Systems, Inc. Improved infrared float bar
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
EP2688561B1 (en) * 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
JP5941466B2 (ja) * 2011-07-21 2016-06-29 帝國製薬株式会社 水性貼付剤
CN102552221B (zh) * 2012-01-11 2013-09-04 中国人民解放军军事医学科学院微生物流行病研究所 一种妥洛特罗贴剂及其制备方法
NZ628481A (en) * 2012-01-11 2016-11-25 Adelaide Res & Innovation Pty Stabilising and analysing fatty acids in a biological sample stored on solid media
AU2013338243B2 (en) 2012-11-02 2016-09-29 Teikoku Seiyaku Co., Ltd. Propynylaminoindan transdermal compositions
US9962349B2 (en) 2014-10-17 2018-05-08 Fidia Farmaceutici S.P.A. Dermal therapeutic system with high adhesivity
EP3395336A1 (en) 2017-04-28 2018-10-31 Nitto Denko Corporation Transdermal absorption preparation
CN109541065B (zh) * 2018-12-04 2019-10-01 山东大学 一种妥洛特罗贴剂的分析方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU578275B2 (en) * 1984-03-01 1988-10-20 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Pharmaceutical compositions
JPH0725669B2 (ja) 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
IT1251469B (it) 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
ES2180546T3 (es) * 1992-07-23 2003-02-16 Hisamitsu Pharmaceutical Co Composicion basica administrable percutaneamente y composicion de farmaco preparada a partir de ella.
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
JP3466305B2 (ja) * 1994-12-12 2003-11-10 久光製薬株式会社 溶解剤および該溶解剤を含有する外用製剤
EP0943330A4 (en) * 1996-10-04 2001-08-16 Saitama Daiichi Seiyaku Kabush BAND AID
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof

Also Published As

Publication number Publication date
JP4874486B2 (ja) 2012-02-15
WO2001028531A1 (de) 2001-04-26
AU7662400A (en) 2001-04-30
AR026040A1 (es) 2002-12-26
DE19950066A1 (de) 2001-04-26
EP1220662B1 (de) 2005-07-06
JP2003528037A (ja) 2003-09-24
KR20020047240A (ko) 2002-06-21
EP1220662A1 (de) 2002-07-10
US7056528B1 (en) 2006-06-06
CA2387143C (en) 2009-06-02
DE50010679D1 (de) 2005-08-11
ES2245648T3 (es) 2006-01-16
KR101014074B1 (ko) 2011-02-14
JP2011252003A (ja) 2011-12-15
ATE299019T1 (de) 2005-07-15
CA2387143A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
PT1220662E (pt) Sistema terapeutico percutaneo que contem cloridrato de tulobuterol para administrar o tulobuterol broncodilatador atraves da pele
PT1304992E (pt) Sistema de distribuição em gel cutâneo para tratamento de desordens da pele
IS5537A (is) Meðferðarvirk blanda til að gefa tolteródín með stýrðri losun
PT1303261E (pt) Sistema para administracao de drogas auto-emulsionaveis, para drogas lipofilas extremamente insoluveis em agua
CU23040A3 (es) Sistema de administracion controlada de droga por via oral que proporciona control temporal y espacial
BR9609796A (pt) Sistema transcórneo de liberação de droga
PT1238658E (pt) Administracao controlada de um agente activo que utiliza um sistema implantavel
PT1031346E (pt) Vacinacao nao invasiva atraves da pele
DK1100474T5 (da) Todelt kapsel til optag af farmaceutiske tilberedninger til inhalatorer
DK1208864T4 (da) Forbedringer til lægemiddelafgivelsesindretninger
DK1034008T3 (da) Dosisindstillende indretning til medicinske injektorer
ATE298260T1 (de) Sport-trainings-vorrichtung sowie sport-trainings-system
BR9811113B1 (pt) composição tópica para o cuidado da pele.
DK1091734T3 (da) Fremgangsmåde til reduktion af de skadelige virkninger af stråleterapi på animalsk hud og slimhinde
PT1089719E (pt) Sistema terapeutico transdermico que contem hormonas e inibidores de cristalizacao
NO985342L (no) Preparat for behandling Ún gang pr. dag av syklooksygenase-2-medierte sykdommer
BR9606577A (pt) Formulação cosmética e farmacêutica de antiandróginos de origem natural (vegetal) para aplicação tópica percutânea
PT1214052E (pt) Formulacao veterinaria para a administracao de um medicamento insoluvel em agua a um animal visado, atraves de um sistema de distribuicao de agua
BR9507736A (pt) Sistema de administração transdérmico e processos para intensificar a penetração de um composto selecionado de tiagabina e seus sais e ésteres farmaceuticamente aceitáveis através de pele e membranas humanas e não-humanas e para tratar epilepsia
AU7660900A (en) Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
NO20000376D0 (no) Transdermalt terapeutisk system for frigiving av virkestoff gjennom huden inn i en organisme og fremgangsmåte for påfoering på huden
BR9813529B1 (pt) composição desodorante para aplicação tópica à pele humana.
ITBO990050A0 (it) Sistema a catetere per eseguire un trattamento terapeutico intramiocar dico .
BR9706943A (pt) Formulação de tratamento de pele e seus usos
ES2188021T3 (es) Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.